Pédiatrie Tumeurs solides
CA045-020 (PIVOT IO 020)
Phase 1/2 Study of Bempegaldesleukin in Combination with Nivolumab in Children, Adolescents, and Young Adults with Recurrent or Refractory Malignancies (PIVOT IO 020)
Paris
FRANCOIS DOZ